SIMILAR PATTERNS OF AMINO ACIDS FOR 4P65_A_IPHA101
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1f6f | PLACENTAL LACTOGEN (Ovis aries) |
PF00103(Hormone_1) | 5 | LEU A 172HIS A 98LEU A 97ALA A 100LEU A 157 | None | 1.09A | 4p65A-1f6fA:undetectable4p65B-1f6fA:undetectable4p65F-1f6fA:undetectable4p65H-1f6fA:undetectable | 4p65A-1f6fA:10.424p65B-1f6fA:12.364p65F-1f6fA:12.364p65H-1f6fA:12.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1g4u | PROTEIN TYROSINEPHOSPHATASE SPTP (Salmonellaenterica) |
PF00102(Y_phosphatase)PF03545(YopE) | 5 | LEU S 218LEU S 215ALA S 175LEU S 183LEU S 287 | None | 1.28A | 4p65A-1g4uS:undetectable4p65B-1g4uS:undetectable4p65F-1g4uS:undetectable4p65H-1g4uS:undetectable | 4p65A-1g4uS:5.004p65B-1g4uS:6.654p65F-1g4uS:6.654p65H-1g4uS:6.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1i7k | UBIQUITIN-CONJUGATING ENZYME E2 H10 (Homo sapiens) |
PF00179(UQ_con) | 5 | LEU A 132LEU A 83ALA A 52LEU A 35LEU A 42 | None | 1.02A | 4p65A-1i7kA:undetectable4p65B-1i7kA:undetectable4p65F-1i7kA:undetectable4p65H-1i7kA:undetectable | 4p65A-1i7kA:8.064p65B-1i7kA:9.474p65F-1i7kA:9.474p65H-1i7kA:9.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1j33 | COBT (Thermusthermophilus) |
PF02277(DBI_PRT) | 5 | LEU A 290LEU A 259ALA A 258HIS A 283LEU A 249 | None | 1.08A | 4p65A-1j33A:undetectable4p65B-1j33A:undetectable4p65F-1j33A:undetectable4p65H-1j33A:undetectable | 4p65A-1j33A:5.834p65B-1j33A:5.524p65F-1j33A:5.524p65H-1j33A:5.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1k4y | LIVERCARBOXYLESTERASE (Oryctolaguscuniculus) |
PF00135(COesterase) | 5 | LEU A 372LEU A 380ALA A 377LEU A 420LEU A 403 | None | 1.11A | 4p65A-1k4yA:undetectable4p65B-1k4yA:undetectable4p65F-1k4yA:undetectable4p65H-1k4yA:undetectable | 4p65A-1k4yA:15.564p65B-1k4yA:3.654p65F-1k4yA:3.654p65H-1k4yA:3.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1luf | MUSCLE-SPECIFICTYROSINE KINASERECEPTOR MUSK (Rattusnorvegicus) |
PF07714(Pkinase_Tyr) | 5 | LEU A 855CYH A 698LEU A 702ALA A 705LEU A 791 | None | 1.00A | 4p65A-1lufA:undetectable4p65B-1lufA:undetectable4p65F-1lufA:undetectable4p65H-1lufA:undetectable | 4p65A-1lufA:4.474p65B-1lufA:6.344p65F-1lufA:6.344p65H-1lufA:6.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ojl | TRANSCRIPTIONALREGULATORY PROTEINZRAR (Salmonellaenterica) |
PF00158(Sigma54_activat)PF02954(HTH_8) | 5 | LEU A 277CYH A 198LEU A 239ALA A 279LEU A 302 | None | 1.18A | 4p65A-1ojlA:undetectable4p65B-1ojlA:undetectable4p65F-1ojlA:undetectable4p65H-1ojlA:undetectable | 4p65A-1ojlA:5.304p65B-1ojlA:8.334p65F-1ojlA:8.334p65H-1ojlA:8.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1t6p | PHENYLALANINEAMMONIA-LYASE (Rhodotorulatoruloides) |
PF00221(Lyase_aromatic) | 5 | CYH A 530LEU A 440LEU A 470ALA A 474LEU A 523 | None | 1.28A | 4p65A-1t6pA:undetectable4p65B-1t6pA:undetectable4p65F-1t6pA:undetectable4p65H-1t6pA:undetectable | 4p65A-1t6pA:2.794p65B-1t6pA:4.704p65F-1t6pA:4.704p65H-1t6pA:4.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ttw | SECRETION CHAPERONE (Yersinia pestis) |
PF05932(CesT) | 5 | CYH A 81LEU A 91LEU A 119ALA A 54LEU A 57 | None | 0.92A | 4p65A-1ttwA:undetectable4p65B-1ttwA:undetectable4p65F-1ttwA:undetectable4p65H-1ttwA:undetectable | 4p65A-1ttwA:9.354p65B-1ttwA:15.054p65F-1ttwA:15.054p65H-1ttwA:15.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ug3 | EUKARYOTIC PROTEINSYNTHESIS INITIATIONFACTOR 4G (Homo sapiens) |
PF02020(W2)PF02847(MA3) | 5 | CYH A1488LEU A1505LEU A1550ALA A1549LEU A1543 | None | 1.13A | 4p65A-1ug3A:undetectable4p65B-1ug3A:undetectable4p65F-1ug3A:undetectable4p65H-1ug3A:undetectable | 4p65A-1ug3A:4.554p65B-1ug3A:7.484p65F-1ug3A:7.484p65H-1ug3A:7.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wlj | INTERFERONSTIMULATED GENE20KDA (Homo sapiens) |
PF00929(RNase_T) | 5 | CYH A 28LEU A 25LEU A 98ALA A 97LEU A 91 | None | 1.14A | 4p65A-1wljA:undetectable4p65B-1wljA:undetectable4p65F-1wljA:undetectable4p65H-1wljA:undetectable | 4p65A-1wljA:7.844p65B-1wljA:11.394p65F-1wljA:11.394p65H-1wljA:11.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xdk | RETINOIC ACIDRECEPTOR, BETA (Mus musculus) |
PF00104(Hormone_recep) | 5 | LEU B 348HIS B 188LEU B 321ALA B 324LEU B 239 | None | 1.27A | 4p65A-1xdkB:undetectable4p65B-1xdkB:undetectable4p65F-1xdkB:undetectable4p65H-1xdkB:undetectable | 4p65A-1xdkB:7.504p65B-1xdkB:14.164p65F-1xdkB:14.164p65H-1xdkB:14.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xm9 | PLAKOPHILIN 1 (Homo sapiens) |
PF00514(Arm) | 5 | LEU A 296LEU A 311ALA A 308LEU A 357LEU A 350 | None | 1.11A | 4p65A-1xm9A:undetectable4p65B-1xm9A:undetectable4p65F-1xm9A:undetectable4p65H-1xm9A:undetectable | 4p65A-1xm9A:3.864p65B-1xm9A:6.674p65F-1xm9A:6.674p65H-1xm9A:6.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zel | HYPOTHETICAL PROTEINRV2827C (Mycobacteriumtuberculosis) |
PF09407(AbiEi_1)PF13338(AbiEi_4) | 5 | CYH A 211LEU A 184LEU A 235ALA A 231LEU A 220 | None | 1.12A | 4p65A-1zelA:undetectable4p65B-1zelA:undetectable4p65F-1zelA:undetectable4p65H-1zelA:undetectable | 4p65A-1zelA:4.484p65B-1zelA:8.984p65F-1zelA:8.984p65H-1zelA:8.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bnh | RIBONUCLEASEINHIBITOR (Sus scrofa) |
PF13516(LRR_6) | 5 | CYH A 97LEU A 92LEU A 115LEU A 104LEU A 72 | None | 1.23A | 4p65A-2bnhA:undetectable4p65B-2bnhA:undetectable4p65F-2bnhA:undetectable4p65H-2bnhA:undetectable | 4p65A-2bnhA:8.424p65B-2bnhA:6.594p65F-2bnhA:6.594p65H-2bnhA:6.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cje | DUTPASE (Leishmaniamajor) |
PF08761(dUTPase_2) | 5 | LEU A 209HIS A 180ALA A 178HIS A 82LEU A 24 | NoneNoneNoneDUN A1266 (-3.7A)DUN A1266 (-4.4A) | 1.15A | 4p65A-2cjeA:undetectable4p65B-2cjeA:undetectable4p65F-2cjeA:undetectable4p65H-2cjeA:undetectable | 4p65A-2cjeA:7.664p65B-2cjeA:12.034p65F-2cjeA:12.034p65H-2cjeA:12.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2d96 | NUCLEAR FACTORNF-KAPPA-B P100SUBUNIT (Homo sapiens) |
PF00531(Death) | 5 | LEU A 36LEU A 77ALA A 76LEU A 70LEU A 40 | None | 1.07A | 4p65A-2d96A:undetectable4p65B-2d96A:undetectable4p65F-2d96A:undetectable4p65H-2d96A:undetectable | 4p65A-2d96A:9.174p65B-2d96A:15.844p65F-2d96A:15.844p65H-2d96A:15.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dh3 | 4F2 CELL-SURFACEANTIGEN HEAVY CHAIN (Homo sapiens) |
PF00128(Alpha-amylase) | 5 | LEU A 513LEU A 515ALA A 475LEU A 466LEU A 477 | None | 1.18A | 4p65A-2dh3A:undetectable4p65B-2dh3A:undetectable4p65F-2dh3A:undetectable4p65H-2dh3A:undetectable | 4p65A-2dh3A:4.294p65B-2dh3A:5.724p65F-2dh3A:5.724p65H-2dh3A:5.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2e2c | UBIQUITINCONJUGATING ENZYME (Spisulasolidissima) |
PF00179(UQ_con) | 5 | LEU A 132LEU A 83ALA A 52LEU A 35LEU A 42 | None | 1.08A | 4p65A-2e2cA:undetectable4p65B-2e2cA:undetectable4p65F-2e2cA:undetectable4p65H-2e2cA:undetectable | 4p65A-2e2cA:9.684p65B-2e2cA:9.154p65F-2e2cA:9.154p65H-2e2cA:9.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2efj | 3,7-DIMETHYLXANTHINEMETHYLTRANSFERASE (Coffeacanephora) |
PF03492(Methyltransf_7) | 5 | LEU A 47CYH A 38LEU A 42ALA A 45LEU A 287 | None | 1.07A | 4p65A-2efjA:undetectable4p65B-2efjA:undetectable4p65F-2efjA:undetectable4p65H-2efjA:undetectable | 4p65A-2efjA:6.364p65B-2efjA:6.164p65F-2efjA:6.164p65H-2efjA:6.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fuk | XC6422 PROTEIN (Xanthomonascampestris) |
PF12146(Hydrolase_4) | 5 | LEU A 132CYH A 43LEU A 97ALA A 101LEU A 113 | None | 1.19A | 4p65A-2fukA:undetectable4p65B-2fukA:undetectable4p65F-2fukA:undetectable4p65H-2fukA:undetectable | 4p65A-2fukA:7.454p65B-2fukA:7.314p65F-2fukA:7.314p65H-2fukA:7.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g18 | PHYCOCYANOBILIN:FERREDOXINOXIDOREDUCTASE (Anabaena sp.) |
PF05996(Fe_bilin_red) | 5 | LEU A 84LEU A 20ALA A 21LEU A 181LEU A 72 | None | 1.23A | 4p65A-2g18A:undetectable4p65B-2g18A:undetectable4p65F-2g18A:undetectable4p65H-2g18A:undetectable | 4p65A-2g18A:6.704p65B-2g18A:10.004p65F-2g18A:10.004p65H-2g18A:10.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g8l | 287AA LONGHYPOTHETICAL PROTEIN (Pyrococcushorikoshii) |
PF01937(DUF89) | 5 | LEU A 167CYH A 280LEU A 259ALA A 104LEU A 133 | None | 1.13A | 4p65A-2g8lA:undetectable4p65B-2g8lA:undetectable4p65F-2g8lA:undetectable4p65H-2g8lA:undetectable | 4p65A-2g8lA:4.424p65B-2g8lA:7.174p65F-2g8lA:7.174p65H-2g8lA:7.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gnw | NON-SYMBIOTICHEMOGLOBIN 1 (Oryza sativa) |
PF00042(Globin) | 5 | LEU A 101HIS A 152LEU A 153ALA A 156LEU A 88 | NoneNoneHEM A 166 ( 4.7A)NoneNone | 1.10A | 4p65A-2gnwA:undetectable4p65B-2gnwA:undetectable4p65F-2gnwA:undetectable4p65H-2gnwA:undetectable | 4p65A-2gnwA:5.454p65B-2gnwA:9.704p65F-2gnwA:9.704p65H-2gnwA:9.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hpi | DNA POLYMERASE IIIALPHA SUBUNIT (Thermusaquaticus) |
PF02811(PHP)PF07733(DNA_pol3_alpha)PF14579(HHH_6) | 5 | LEU A 318HIS A 385LEU A 384ALA A 387LEU A 431 | None | 1.24A | 4p65A-2hpiA:undetectable4p65B-2hpiA:undetectable4p65F-2hpiA:undetectable4p65H-2hpiA:undetectable | 4p65A-2hpiA:1.554p65B-2hpiA:2.424p65F-2hpiA:2.424p65H-2hpiA:2.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2lxp | UBIQUITIN-CONJUGATING ENZYME E2 G2 (Homo sapiens) |
PF00179(UQ_con) | 5 | LEU A 120LEU A 58ALA A 26LEU A 9LEU A 16 | None | 0.93A | 4p65A-2lxpA:undetectable4p65B-2lxpA:undetectable4p65F-2lxpA:undetectable4p65H-2lxpA:undetectable | 4p65A-2lxpA:11.304p65B-2lxpA:12.304p65F-2lxpA:12.304p65H-2lxpA:12.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2no5 | (S)-2-HALOACIDDEHALOGENASE IVA (Burkholderiacepacia) |
PF13419(HAD_2) | 5 | CYH A 142LEU A 126ALA A 12LEU A 105LEU A 17 | NoneNoneASL A 11 ( 3.3A)NoneNone | 1.23A | 4p65A-2no5A:undetectable4p65B-2no5A:undetectable4p65F-2no5A:undetectable4p65H-2no5A:undetectable | 4p65A-2no5A:20.344p65B-2no5A:8.564p65F-2no5A:8.564p65H-2no5A:8.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homo sapiens) |
PF00104(Hormone_recep) | 5 | CYH A 384LEU A 308HIS A 396LEU A 300LEU A 391 | None | 1.22A | 4p65A-2p54A:undetectable4p65B-2p54A:undetectable4p65F-2p54A:undetectable4p65H-2p54A:undetectable | 4p65A-2p54A:5.664p65B-2p54A:10.004p65F-2p54A:10.004p65H-2p54A:10.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pbj | PROSTAGLANDIN ESYNTHASE 2 (Macacafascicularis) |
PF13417(GST_N_3) | 5 | LEU A 182LEU A 162ALA A 153LEU A 120LEU A 100 | None | 1.12A | 4p65A-2pbjA:undetectable4p65B-2pbjA:undetectable4p65F-2pbjA:undetectable4p65H-2pbjA:undetectable | 4p65A-2pbjA:3.794p65B-2pbjA:9.024p65F-2pbjA:9.024p65H-2pbjA:9.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q0f | RNA URIDYLYLTRANSFERASE (Trypanosomabrucei) |
PF03828(PAP_assoc) | 5 | HIS A 320LEU A 321ALA A 324LEU A 177LEU A 329 | None | 1.09A | 4p65A-2q0fA:undetectable4p65B-2q0fA:undetectable4p65F-2q0fA:undetectable4p65H-2q0fA:undetectable | 4p65A-2q0fA:5.484p65B-2q0fA:6.344p65F-2q0fA:6.344p65H-2q0fA:6.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q0f | RNA URIDYLYLTRANSFERASE (Trypanosomabrucei) |
PF03828(PAP_assoc) | 5 | LEU A 245HIS A 320ALA A 324LEU A 177LEU A 329 | None | 1.18A | 4p65A-2q0fA:undetectable4p65B-2q0fA:undetectable4p65F-2q0fA:undetectable4p65H-2q0fA:undetectable | 4p65A-2q0fA:5.484p65B-2q0fA:6.344p65F-2q0fA:6.344p65H-2q0fA:6.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rdy | BH0842 PROTEIN (Bacillushalodurans) |
PF14498(Glyco_hyd_65N_2) | 5 | LEU A 234LEU A 244ALA A 220LEU A 159LEU A 227 | None | 1.21A | 4p65A-2rdyA:undetectable4p65B-2rdyA:undetectable4p65F-2rdyA:undetectable4p65H-2rdyA:undetectable | 4p65A-2rdyA:7.144p65B-2rdyA:4.654p65F-2rdyA:4.654p65H-2rdyA:4.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rgj | FLAVIN-CONTAININGMONOOXYGENASE (Pseudomonasaeruginosa) |
PF01494(FAD_binding_3) | 5 | HIS A 24LEU A 23ALA A 22LEU A 121LEU A 60 | None | 1.24A | 4p65A-2rgjA:undetectable4p65B-2rgjA:undetectable4p65F-2rgjA:undetectable4p65H-2rgjA:undetectable | 4p65A-2rgjA:3.914p65B-2rgjA:4.994p65F-2rgjA:4.994p65H-2rgjA:4.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vg2 | UNDECAPRENYLPYROPHOSPHATESYNTHETASE (Mycobacteriumtuberculosis) |
PF01255(Prenyltransf) | 5 | CYH A 283LEU A 279LEU A 110ALA A 107LEU A 115 | None | 1.21A | 4p65A-2vg2A:undetectable4p65B-2vg2A:undetectable4p65F-2vg2A:undetectable4p65H-2vg2A:undetectable | 4p65A-2vg2A:10.004p65B-2vg2A:9.334p65F-2vg2A:9.334p65H-2vg2A:9.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w2d | BOTULINUM NEUROTOXINA HEAVY CHAIN (Clostridiumbotulinum) |
PF07952(Toxin_trans) | 5 | LEU B 815LEU B 699ALA B 698LEU B 837LEU B 681 | None | 1.19A | 4p65A-2w2dB:undetectable4p65B-2w2dB:undetectable4p65F-2w2dB:undetectable4p65H-2w2dB:undetectable | 4p65A-2w2dB:6.764p65B-2w2dB:6.144p65F-2w2dB:6.144p65H-2w2dB:6.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3a9x | SELENOCYSTEINE LYASE (Rattusnorvegicus) |
PF00266(Aminotran_5) | 5 | LEU A 367CYH A 346LEU A 403ALA A 369LEU A 361 | None | 1.12A | 4p65A-3a9xA:undetectable4p65B-3a9xA:undetectable4p65F-3a9xA:undetectable4p65H-3a9xA:undetectable | 4p65A-3a9xA:5.624p65B-3a9xA:5.574p65F-3a9xA:5.574p65H-3a9xA:5.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3aq0 | GERANYL DIPHOSPHATESYNTHASE (Arabidopsisthaliana) |
PF00348(polyprenyl_synt) | 5 | LEU A 197LEU A 165ALA A 161LEU A 139LEU A 158 | NoneFPP A1002 ( 4.6A)NoneNoneNone | 1.27A | 4p65A-3aq0A:undetectable4p65B-3aq0A:undetectable4p65F-3aq0A:undetectable4p65H-3aq0A:undetectable | 4p65A-3aq0A:4.034p65B-3aq0A:8.804p65F-3aq0A:8.804p65H-3aq0A:8.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cit | SENSOR HISTIDINEKINASE (Pseudomonassyringae groupgenomosp. 3) |
no annotation | 5 | LEU A 131LEU A 51ALA A 54LEU A 155LEU A 148 | None | 0.99A | 4p65A-3citA:undetectable4p65B-3citA:undetectable4p65F-3citA:undetectable4p65H-3citA:undetectable | 4p65A-3citA:11.904p65B-3citA:14.414p65F-3citA:14.414p65H-3citA:14.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3e7w | D-ALANINE--POLY(PHOSPHORIBITOL) LIGASESUBUNIT 1 (Bacillussubtilis) |
PF00501(AMP-binding)PF13193(AMP-binding_C) | 5 | LEU A 206CYH A 214LEU A 212ALA A 19LEU A 32 | None | 1.09A | 4p65A-3e7wA:undetectable4p65B-3e7wA:undetectable4p65F-3e7wA:undetectable4p65H-3e7wA:undetectable | 4p65A-3e7wA:3.914p65B-3e7wA:7.974p65F-3e7wA:7.974p65H-3e7wA:7.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h0r | ASPARTYL/GLUTAMYL-TRNA(ASN/GLN)AMIDOTRANSFERASESUBUNIT B (Aquifexaeolicus) |
PF02637(GatB_Yqey)PF02934(GatB_N) | 5 | CYH B 194LEU B 11LEU B 170ALA B 166LEU B 227 | None | 1.19A | 4p65A-3h0rB:undetectable4p65B-3h0rB:undetectable4p65F-3h0rB:undetectable4p65H-3h0rB:undetectable | 4p65A-3h0rB:8.434p65B-3h0rB:4.834p65F-3h0rB:4.834p65H-3h0rB:4.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hmj | FATTY ACID SYNTHASESUBUNIT ALPHA (Saccharomycescerevisiae) |
PF00109(ketoacyl-synt)PF01648(ACPS)PF02801(Ketoacyl-synt_C) | 5 | LEU A 908HIS A 639LEU A 640ALA A 924LEU A 926 | None | 1.19A | 4p65A-3hmjA:undetectable4p65B-3hmjA:undetectable4p65F-3hmjA:undetectable4p65H-3hmjA:undetectable | 4p65A-3hmjA:1.884p65B-3hmjA:2.844p65F-3hmjA:2.844p65H-3hmjA:2.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3m9v | FAD-DEPENDENTOXIDOREDUCTASE (Actinomadurakijaniata) |
PF00441(Acyl-CoA_dh_1)PF02770(Acyl-CoA_dh_M)PF02771(Acyl-CoA_dh_N) | 5 | LEU A 313LEU A 262ALA A 83LEU A 305LEU A 14 | None | 1.28A | 4p65A-3m9vA:undetectable4p65B-3m9vA:undetectable4p65F-3m9vA:undetectable4p65H-3m9vA:undetectable | 4p65A-3m9vA:3.554p65B-3m9vA:10.264p65F-3m9vA:10.264p65H-3m9vA:10.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mdy | BONE MORPHOGENETICPROTEIN RECEPTORTYPE-1B (Homo sapiens) |
PF07714(Pkinase_Tyr)PF08515(TGF_beta_GS) | 5 | LEU A 491LEU A 302ALA A 305LEU A 463LEU A 407 | None | 1.09A | 4p65A-3mdyA:undetectable4p65B-3mdyA:undetectable4p65F-3mdyA:undetectable4p65H-3mdyA:undetectable | 4p65A-3mdyA:5.654p65B-3mdyA:5.974p65F-3mdyA:5.974p65H-3mdyA:5.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3owc | PROBABLEACETYLTRANSFERASE (Pseudomonasaeruginosa) |
PF00583(Acetyltransf_1) | 5 | CYH A 81LEU A 14LEU A 116ALA A 115LEU A 12 | None | 1.23A | 4p65A-3owcA:undetectable4p65B-3owcA:undetectable4p65F-3owcA:undetectable4p65H-3owcA:undetectable | 4p65A-3owcA:7.494p65B-3owcA:11.894p65F-3owcA:11.894p65H-3owcA:11.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3oxn | PUTATIVETRANSCRIPTIONALREGULATOR, LYSRFAMILY (Vibrioparahaemolyticus) |
PF03466(LysR_substrate) | 5 | LEU A 232CYH A 192LEU A 282HIS A 215LEU A 211 | None | 1.19A | 4p65A-3oxnA:undetectable4p65B-3oxnA:undetectable4p65F-3oxnA:undetectable4p65H-3oxnA:undetectable | 4p65A-3oxnA:6.874p65B-3oxnA:11.524p65F-3oxnA:11.524p65H-3oxnA:11.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pfo | PUTATIVEACETYLORNITHINEDEACETYLASE (Rhodopseudomonaspalustris) |
PF01546(Peptidase_M20)PF07687(M20_dimer) | 5 | LEU A 327CYH A 292ALA A 332LEU A 294LEU A 317 | None | 1.26A | 4p65A-3pfoA:undetectable4p65B-3pfoA:undetectable4p65F-3pfoA:undetectable4p65H-3pfoA:undetectable | 4p65A-3pfoA:3.834p65B-3pfoA:6.674p65F-3pfoA:6.674p65H-3pfoA:6.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3r7p | RIBOSOMAL PROTEIN3/HOMINGENDONUCLEASE-LIKEFUSION PROTEIN (Leptographiumtruncatum) |
PF00961(LAGLIDADG_1) | 5 | LEU A 139HIS A 127LEU A 121ALA A 118LEU A 34 | None | 1.28A | 4p65A-3r7pA:undetectable4p65B-3r7pA:undetectable4p65F-3r7pA:undetectable4p65H-3r7pA:undetectable | 4p65A-3r7pA:8.444p65B-3r7pA:9.904p65F-3r7pA:9.904p65H-3r7pA:9.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rj8 | CARBOHYDRATE OXIDASE (Microdochiumnivale) |
PF01565(FAD_binding_4)PF08031(BBE) | 5 | CYH A 55CYH A 6LEU A 7LEU A 84ALA A 39 | None | 1.26A | 4p65A-3rj8A:undetectable4p65B-3rj8A:undetectable4p65F-3rj8A:undetectable4p65H-3rj8A:undetectable | 4p65A-3rj8A:4.454p65B-3rj8A:5.844p65F-3rj8A:5.844p65H-3rj8A:5.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sdi | PROTEASOME COMPONENTPRE5 (Saccharomycescerevisiae) |
PF00227(Proteasome)PF10584(Proteasome_A_N) | 5 | CYH E 70LEU E 92ALA E 112HIS E 73LEU E 107 | None | 0.93A | 4p65A-3sdiE:undetectable4p65B-3sdiE:undetectable4p65F-3sdiE:undetectable4p65H-3sdiE:undetectable | 4p65A-3sdiE:13.954p65B-3sdiE:9.914p65F-3sdiE:9.914p65H-3sdiE:9.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3so4 | METHIONINE-ADENOSYLTRANSFERASE (Entamoebahistolytica) |
PF00438(S-AdoMet_synt_N)PF02772(S-AdoMet_synt_M)PF02773(S-AdoMet_synt_C) | 5 | CYH A 298LEU A 292LEU A 332LEU A 388LEU A 382 | None | 1.24A | 4p65A-3so4A:undetectable4p65B-3so4A:undetectable4p65F-3so4A:undetectable4p65H-3so4A:undetectable | 4p65A-3so4A:5.504p65B-3so4A:3.954p65F-3so4A:3.954p65H-3so4A:3.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3su8 | PLEXIN-B1 (Homo sapiens) |
PF08337(Plexin_cytopl) | 5 | HIS X2089LEU X2088ALA X2087LEU X1589LEU X1585 | None | 1.21A | 4p65A-3su8X:undetectable4p65B-3su8X:undetectable4p65F-3su8X:undetectable4p65H-3su8X:undetectable | 4p65A-3su8X:3.364p65B-3su8X:7.454p65F-3su8X:7.454p65H-3su8X:7.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3t5q | NUCLEOPROTEIN (Mopeia Lassavirusreassortant 29) |
PF00843(Arena_nucleocap) | 5 | CYH A 186HIS A 40LEU A 38ALA A 35LEU A 195 | NonePO4 A 341 ( 4.7A)NoneNoneNone | 1.28A | 4p65A-3t5qA:undetectable4p65B-3t5qA:undetectable4p65F-3t5qA:undetectable4p65H-3t5qA:undetectable | 4p65A-3t5qA:5.634p65B-3t5qA:5.594p65F-3t5qA:5.594p65H-3t5qA:5.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3uyq | CARBONIC ANHYDRASE 3 (Homo sapiens) |
PF00194(Carb_anhydrase) | 5 | CYH A 66LEU A 225HIS A 119ALA A 116LEU A 147 | NoneNone ZN A 261 (-3.2A)NoneNone | 1.25A | 4p65A-3uyqA:undetectable4p65B-3uyqA:undetectable4p65F-3uyqA:undetectable4p65H-3uyqA:undetectable | 4p65A-3uyqA:11.504p65B-3uyqA:12.724p65F-3uyqA:12.724p65H-3uyqA:12.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w94 | ENTEROPEPTIDASE-1 (Oryzias latipes) |
PF00089(Trypsin) | 5 | LEU A 831HIS A 813LEU A 812ALA A 850LEU A 852 | None | 1.27A | 4p65A-3w94A:undetectable4p65B-3w94A:undetectable4p65F-3w94A:undetectable4p65H-3w94A:undetectable | 4p65A-3w94A:4.724p65B-3w94A:9.014p65F-3w94A:9.014p65H-3w94A:9.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wqf | D-THREO-3-HYDROXYASPARTATE DEHYDRATASE (Delftia sp.HT23) |
PF01168(Ala_racemase_N)PF14031(D-ser_dehydrat) | 5 | LEU A 67CYH A 103LEU A 98ALA A 95LEU A 107 | None | 1.09A | 4p65A-3wqfA:undetectable4p65B-3wqfA:undetectable4p65F-3wqfA:undetectable4p65H-3wqfA:undetectable | 4p65A-3wqfA:3.854p65B-3wqfA:7.694p65F-3wqfA:7.694p65H-3wqfA:7.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ah6 | ASPARTATE--TRNALIGASE,MITOCHONDRIAL (Homo sapiens) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon)PF02938(GAD) | 5 | LEU A 567LEU A 249ALA A 570HIS A 578LEU A 571 | None | 1.23A | 4p65A-4ah6A:undetectable4p65B-4ah6A:undetectable4p65F-4ah6A:undetectable4p65H-4ah6A:undetectable | 4p65A-4ah6A:2.424p65B-4ah6A:5.304p65F-4ah6A:5.304p65H-4ah6A:5.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dkb | DEOXYURIDINETRIPHOSPHATASE (Trypanosomabrucei) |
PF08761(dUTPase_2) | 5 | LEU A 238HIS A 209ALA A 207HIS A 82LEU A 24 | NoneNoneNoneDUN A 303 (-3.7A)DUN A 303 (-4.3A) | 1.09A | 4p65A-4dkbA:undetectable4p65B-4dkbA:undetectable4p65F-4dkbA:undetectable4p65H-4dkbA:undetectable | 4p65A-4dkbA:5.044p65B-4dkbA:7.534p65F-4dkbA:7.534p65H-4dkbA:7.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4eoc | PHYCOCYANOBILIN:FERREDOXINOXIDOREDUCTASE (Synechocystissp. PCC 6803) |
PF05996(Fe_bilin_red) | 5 | LEU A 87LEU A 24ALA A 25LEU A 184LEU A 75 | None | 1.24A | 4p65A-4eocA:undetectable4p65B-4eocA:undetectable4p65F-4eocA:undetectable4p65H-4eocA:undetectable | 4p65A-4eocA:8.674p65B-4eocA:9.744p65F-4eocA:9.744p65H-4eocA:9.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fqd | NIKO PROTEIN (Streptomycestendae) |
PF00275(EPSP_synthase) | 5 | CYH A 273LEU A 417ALA A 418LEU A 350LEU A 375 | None | 1.26A | 4p65A-4fqdA:undetectable4p65B-4fqdA:undetectable4p65F-4fqdA:undetectable4p65H-4fqdA:undetectable | 4p65A-4fqdA:3.824p65B-4fqdA:4.304p65F-4fqdA:4.304p65H-4fqdA:4.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4g3a | CLIP-ASSOCIATINGPROTEIN (Drosophilamelanogaster) |
PF12348(CLASP_N) | 5 | LEU A 31LEU A 35ALA A 72LEU A 80LEU A 54 | None | 1.15A | 4p65A-4g3aA:undetectable4p65B-4g3aA:undetectable4p65F-4g3aA:undetectable4p65H-4g3aA:undetectable | 4p65A-4g3aA:7.984p65B-4g3aA:9.274p65F-4g3aA:9.274p65H-4g3aA:9.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gax | AMORPHA-4,11-DIENESYNTHASE (Artemisia annua) |
PF01397(Terpene_synth)PF03936(Terpene_synth_C) | 5 | CYH A 119LEU A 160ALA A 163HIS A 125LEU A 146 | None | 1.27A | 4p65A-4gaxA:undetectable4p65B-4gaxA:undetectable4p65F-4gaxA:undetectable4p65H-4gaxA:undetectable | 4p65A-4gaxA:2.904p65B-4gaxA:4.324p65F-4gaxA:4.324p65H-4gaxA:4.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gis | ENOLASE (Vibrio harveyi) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 5 | CYH A 279CYH A 297LEU A 293ALA A 290LEU A 323 | None | 1.26A | 4p65A-4gisA:undetectable4p65B-4gisA:undetectable4p65F-4gisA:undetectable4p65H-4gisA:undetectable | 4p65A-4gisA:4.794p65B-4gisA:6.944p65F-4gisA:6.944p65H-4gisA:6.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h0o | ACETATE KINASE (Entamoebahistolytica) |
PF00871(Acetate_kinase) | 5 | CYH A 197CYH A 206LEU A 227LEU A 199HIS A 172 | None | 1.22A | 4p65A-4h0oA:undetectable4p65B-4h0oA:undetectable4p65F-4h0oA:undetectable4p65H-4h0oA:undetectable | 4p65A-4h0oA:3.984p65B-4h0oA:6.884p65F-4h0oA:6.884p65H-4h0oA:6.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ivn | TRANSCRIPTIONALREGULATOR (Vibriovulnificus) |
PF01380(SIS)PF01418(HTH_6) | 5 | LEU A 8LEU A 30ALA A 33LEU A 58LEU A 74 | None | 1.17A | 4p65A-4ivnA:undetectable4p65B-4ivnA:undetectable4p65F-4ivnA:undetectable4p65H-4ivnA:undetectable | 4p65A-4ivnA:5.784p65B-4ivnA:8.054p65F-4ivnA:8.054p65H-4ivnA:8.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k17 | LEUCINE-RICHREPEAT-CONTAININGPROTEIN 16A (Mus musculus) |
PF13516(LRR_6) | 5 | LEU A 288LEU A 258ALA A 263LEU A 251LEU A 296 | None | 1.24A | 4p65A-4k17A:undetectable4p65B-4k17A:undetectable4p65F-4k17A:undetectable4p65H-4k17A:undetectable | 4p65A-4k17A:2.624p65B-4k17A:4.194p65F-4k17A:4.194p65H-4k17A:4.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4l6u | PUTATIVEUNCHARACTERIZEDPROTEIN (Archaeoglobusfulgidus) |
PF03787(RAMPs) | 5 | CYH A 130LEU A 158LEU A 164LEU A 181LEU A 167 | None | 1.24A | 4p65A-4l6uA:undetectable4p65B-4l6uA:undetectable4p65F-4l6uA:undetectable4p65H-4l6uA:undetectable | 4p65A-4l6uA:8.944p65B-4l6uA:7.144p65F-4l6uA:7.144p65H-4l6uA:7.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nph | PROBABLE SECRETIONSYSTEM APPARATUS ATPSYNTHASE SSAN (Salmonellaenterica) |
PF00006(ATP-synt_ab) | 5 | LEU A 230LEU A 254ALA A 251LEU A 325LEU A 249 | None | 0.86A | 4p65A-4nphA:undetectable4p65B-4nphA:undetectable4p65F-4nphA:undetectable4p65H-4nphA:undetectable | 4p65A-4nphA:5.994p65B-4nphA:8.984p65F-4nphA:8.984p65H-4nphA:8.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o89 | RNA 3'-TERMINALPHOSPHATE CYCLASE (Pyrococcushorikoshii) |
PF01137(RTC)PF05189(RTC_insert) | 5 | CYH A 279LEU A 245ALA A 139LEU A 292LEU A 284 | None | 1.17A | 4p65A-4o89A:undetectable4p65B-4o89A:undetectable4p65F-4o89A:undetectable4p65H-4o89A:undetectable | 4p65A-4o89A:8.284p65B-4o89A:7.544p65F-4o89A:7.544p65H-4o89A:7.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o89 | RNA 3'-TERMINALPHOSPHATE CYCLASE (Pyrococcushorikoshii) |
PF01137(RTC)PF05189(RTC_insert) | 5 | CYH A 279LEU A 245LEU A 177ALA A 139LEU A 284 | None | 1.20A | 4p65A-4o89A:undetectable4p65B-4o89A:undetectable4p65F-4o89A:undetectable4p65H-4o89A:undetectable | 4p65A-4o89A:8.284p65B-4o89A:7.544p65F-4o89A:7.544p65H-4o89A:7.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ppz | SUCCINYL-DIAMINOPIMELATE DESUCCINYLASE (Neisseriameningitidis) |
PF01546(Peptidase_M20)PF07687(M20_dimer) | 5 | LEU A 216LEU A 213ALA A 212LEU A 252LEU A 277 | None | 0.96A | 4p65A-4ppzA:undetectable4p65B-4ppzA:undetectable4p65F-4ppzA:undetectable4p65H-4ppzA:undetectable | 4p65A-4ppzA:4.924p65B-4ppzA:7.894p65F-4ppzA:7.894p65H-4ppzA:7.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rq9 | PHOTORECEPTOR-HISTIDINE KINASE BPHP (Stigmatellaaurantiaca) |
PF01590(GAF)PF08446(PAS_2) | 5 | LEU A 89LEU A 95ALA A 112LEU A 68LEU A 119 | None | 1.21A | 4p65A-4rq9A:undetectable4p65B-4rq9A:undetectable4p65F-4rq9A:undetectable4p65H-4rq9A:undetectable | 4p65A-4rq9A:5.494p65B-4rq9A:6.694p65F-4rq9A:6.694p65H-4rq9A:6.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wj7 | MALCAVERNIN (Homo sapiens) |
no annotation | 5 | LEU A 70HIS A 151LEU A 152ALA A 199LEU A 105 | None | 1.22A | 4p65A-4wj7A:undetectable4p65B-4wj7A:undetectable4p65F-4wj7A:undetectable4p65H-4wj7A:undetectable | 4p65A-4wj7A:6.754p65B-4wj7A:14.074p65F-4wj7A:14.074p65H-4wj7A:14.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wja | UNCHARACTERIZEDPROTEIN C9ORF142 (Homo sapiens) |
PF15384(PAXX) | 5 | CYH A 22LEU A 87ALA A 94LEU A 47LEU A 89 | None | 1.05A | 4p65A-4wjaA:undetectable4p65B-4wjaA:undetectable4p65F-4wjaA:undetectable4p65H-4wjaA:undetectable | 4p65A-4wjaA:11.464p65B-4wjaA:11.184p65F-4wjaA:11.184p65H-4wjaA:11.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yam | BETA-ETHERASE (Sphingobium sp.SYK-6) |
PF13417(GST_N_3) | 5 | LEU A 102LEU A 106ALA A 191LEU A 213LEU A 179 | None | 1.28A | 4p65A-4yamA:undetectable4p65B-4yamA:undetectable4p65F-4yamA:undetectable4p65H-4yamA:undetectable | 4p65A-4yamA:6.424p65B-4yamA:7.124p65F-4yamA:7.124p65H-4yamA:7.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yff | SERINE/THREONINE-PROTEIN KINASE TNNI3K (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | CYH A 722LEU A 719LEU A 564ALA A 567LEU A 655 | None | 1.26A | 4p65A-4yffA:undetectable4p65B-4yffA:undetectable4p65F-4yffA:undetectable4p65H-4yffA:undetectable | 4p65A-4yffA:4.904p65B-4yffA:8.294p65F-4yffA:8.294p65H-4yffA:8.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yii | UBIQUITIN-CONJUGATING ENZYME E2 C (Homo sapiens) |
PF00179(UQ_con) | 5 | LEU U 132LEU U 83ALA U 52LEU U 35LEU U 42 | None | 1.08A | 4p65A-4yiiU:undetectable4p65B-4yiiU:undetectable4p65F-4yiiU:undetectable4p65H-4yiiU:undetectable | 4p65A-4yiiU:8.064p65B-4yiiU:11.034p65F-4yiiU:11.034p65H-4yiiU:11.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yu5 | IMMUNE INHIBITOR A,METALLOPROTEASE (Bacillus cereus) |
PF05547(Peptidase_M6) | 5 | LEU A 169HIS A 275LEU A 274ALA A 277LEU A 241 | None | 1.18A | 4p65A-4yu5A:undetectable4p65B-4yu5A:undetectable4p65F-4yu5A:undetectable4p65H-4yu5A:undetectable | 4p65A-4yu5A:2.584p65B-4yu5A:3.944p65F-4yu5A:3.944p65H-4yu5A:3.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ejy | MYOSIN-I HEAVY CHAIN (Dictyosteliumdiscoideum) |
PF00784(MyTH4) | 5 | LEU A 466LEU A 524ALA A 516LEU A 497LEU A 514 | None | 1.24A | 4p65A-5ejyA:undetectable4p65B-5ejyA:undetectable4p65F-5ejyA:undetectable4p65H-5ejyA:undetectable | 4p65A-5ejyA:7.264p65B-5ejyA:4.744p65F-5ejyA:4.744p65H-5ejyA:4.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fje | COPPER STORAGEPROTEIN 1 (Methylosinustrichosporium) |
no annotation | 5 | CYH A 110LEU A 58CYH A 117ALA A 61LEU A 19 | CU1 A1127 ( 2.1A)CU1 A1127 ( 4.2A)CU1 A1123 ( 2.1A)NoneCU1 A1123 (-4.9A) | 1.19A | 4p65A-5fjeA:undetectable4p65B-5fjeA:undetectable4p65F-5fjeA:undetectable4p65H-5fjeA:undetectable | 4p65A-5fjeA:8.334p65B-5fjeA:14.634p65F-5fjeA:14.634p65H-5fjeA:14.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5h7c | IMMUNOGLOBULING-BINDING PROTEIN A,DHR14 (Staphylococcusaureus;syntheticconstruct) |
PF02216(B) | 5 | LEU A 376LEU A 356ALA A 357LEU A 368LEU A 399 | None | 1.27A | 4p65A-5h7cA:undetectable4p65B-5h7cA:undetectable4p65F-5h7cA:undetectable4p65H-5h7cA:undetectable | 4p65A-5h7cA:2.974p65B-5h7cA:5.884p65F-5h7cA:5.884p65H-5h7cA:5.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5k13 | RETINOIC ACIDRECEPTOR ALPHA (Homo sapiens) |
PF00104(Hormone_recep) | 5 | LEU A 355HIS A 195LEU A 328ALA A 331LEU A 246 | None | 1.22A | 4p65A-5k13A:undetectable4p65B-5k13A:undetectable4p65F-5k13A:undetectable4p65H-5k13A:undetectable | 4p65A-5k13A:7.234p65B-5k13A:15.324p65F-5k13A:15.324p65H-5k13A:15.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5loi | RAD26 (Thermothelomycesthermophila) |
PF12331(DUF3636) | 5 | CYH A 483LEU A 479LEU A 526ALA A 529LEU A 464 | None | 1.20A | 4p65A-5loiA:undetectable4p65B-5loiA:undetectable4p65F-5loiA:undetectable4p65H-5loiA:undetectable | 4p65A-5loiA:6.884p65B-5loiA:5.664p65F-5loiA:5.664p65H-5loiA:5.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5loz | EPSIN-1 (Saccharomycescerevisiae) |
PF01417(ENTH) | 5 | LEU A 77LEU A 129ALA A 126LEU A 99LEU A 105 | None | 1.28A | 4p65A-5lozA:undetectable4p65B-5lozA:undetectable4p65F-5lozA:undetectable4p65H-5lozA:undetectable | 4p65A-5lozA:8.734p65B-5lozA:15.384p65F-5lozA:15.384p65H-5lozA:15.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ool | 39S RIBOSOMALPROTEIN L37,MITOCHONDRIAL (Homo sapiens) |
PF07147(PDCD9) | 5 | LEU 5 198HIS 5 420LEU 5 419ALA 5 422HIS 5 289 | None | 1.10A | 4p65A-5ool5:undetectable4p65B-5ool5:undetectable4p65F-5ool5:undetectable4p65H-5ool5:undetectable | 4p65A-5ool5:4.704p65B-5ool5:6.424p65F-5ool5:6.424p65H-5ool5:6.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5t8y | EPOXYQUEUOSINEREDUCTASE (Bacillussubtilis) |
PF08331(DUF1730)PF13484(Fer4_16)PF13646(HEAT_2) | 5 | CYH A 156LEU A 209CYH A 194LEU A 203ALA A 202 | B12 A 503 ( 4.5A)B12 A 503 ( 3.9A)SF4 A 501 (-2.2A)SF4 A 502 ( 4.6A)SF4 A 502 ( 3.9A) | 1.07A | 4p65A-5t8yA:undetectable4p65B-5t8yA:undetectable4p65F-5t8yA:undetectable4p65H-5t8yA:undetectable | 4p65A-5t8yA:3.624p65B-5t8yA:5.664p65F-5t8yA:5.664p65H-5t8yA:5.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tf2 | PROLACTIN REGULATORYELEMENT-BINDINGPROTEIN (Homo sapiens) |
PF00400(WD40) | 5 | LEU A 382LEU A 380ALA A 368LEU A 50LEU A 362 | None | 1.27A | 4p65A-5tf2A:undetectable4p65B-5tf2A:undetectable4p65F-5tf2A:undetectable4p65H-5tf2A:undetectable | 4p65A-5tf2A:6.404p65B-5tf2A:5.594p65F-5tf2A:5.594p65H-5tf2A:5.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5u4z | REPRESSOR OF RNAPOLYMERASE IIITRANSCRIPTION (Citrus sinensis) |
PF09174(Maf1) | 5 | LEU A 145LEU A 141ALA A 144LEU A 16LEU A 9 | None | 1.06A | 4p65A-5u4zA:undetectable4p65B-5u4zA:undetectable4p65F-5u4zA:undetectable4p65H-5u4zA:undetectable | 4p65A-5u4zA:5.704p65B-5u4zA:7.944p65F-5u4zA:7.944p65H-5u4zA:7.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uan | RETINOIC ACIDRECEPTOR BETA (Homo sapiens) |
no annotation | 5 | LEU B 348HIS B 188LEU B 321ALA B 324LEU B 239 | None | 1.23A | 4p65A-5uanB:undetectable4p65B-5uanB:undetectable4p65F-5uanB:undetectable4p65H-5uanB:undetectable | 4p65A-5uanB:4.664p65B-5uanB:6.254p65F-5uanB:6.254p65H-5uanB:6.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ux2 | ALDEHYDEDECARBONYLASE (Synechococcussp. RS9917) |
no annotation | 5 | CYH A 110LEU A 106HIS A 141LEU A 142ALA A 145 | NoneNone FE A 301 (-3.5A)NoneNone | 1.09A | 4p65A-5ux2A:undetectable4p65B-5ux2A:undetectable4p65F-5ux2A:undetectable4p65H-5ux2A:undetectable | 4p65A-5ux2A:undetectable4p65B-5ux2A:undetectable4p65F-5ux2A:undetectable4p65H-5ux2A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vfr | PROTEASOME SUBUNITALPHA TYPE-4 (Homo sapiens) |
no annotation | 5 | LEU I 35LEU I 44ALA I 46LEU I 236LEU I 197 | None | 1.11A | 4p65A-5vfrI:undetectable4p65B-5vfrI:undetectable4p65F-5vfrI:undetectable4p65H-5vfrI:undetectable | 4p65A-5vfrI:undetectable4p65B-5vfrI:undetectable4p65F-5vfrI:undetectable4p65H-5vfrI:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wco | NS2 (Salmon isavirus) |
no annotation | 5 | LEU A 146HIS A 178LEU A 180ALA A 176LEU A 192 | None | 1.19A | 4p65A-5wcoA:undetectable4p65B-5wcoA:undetectable4p65F-5wcoA:undetectable4p65H-5wcoA:undetectable | 4p65A-5wcoA:5.884p65B-5wcoA:10.194p65F-5wcoA:10.194p65H-5wcoA:10.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x09 | V-TYPE ATP SYNTHASEALPHA CHAIN,V-TYPEATP SYNTHASE ALPHACHAIN (Pyrococcushorikoshii) |
no annotation | 5 | LEU A 466LEU A 433HIS A 426LEU A 421LEU A 503 | None | 1.25A | 4p65A-5x09A:undetectable4p65B-5x09A:undetectable4p65F-5x09A:undetectable4p65H-5x09A:undetectable | 4p65A-5x09A:3.614p65B-5x09A:4.324p65F-5x09A:4.324p65H-5x09A:4.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xeq | NEUROLIGIN-2 (Homo sapiens) |
PF00135(COesterase) | 5 | LEU A 245LEU A 242ALA A 241LEU A 183LEU A 144 | None | 1.24A | 4p65A-5xeqA:undetectable4p65B-5xeqA:undetectable4p65F-5xeqA:undetectable4p65H-5xeqA:undetectable | 4p65A-5xeqA:3.384p65B-5xeqA:5.024p65F-5xeqA:5.024p65H-5xeqA:5.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5yjh | PERIOSTIN (Homo sapiens) |
no annotation | 5 | LEU A 247HIS A 359LEU A 360ALA A 273LEU A 271 | MG A 723 ( 4.7A)NoneNoneNoneNone | 0.94A | 4p65A-5yjhA:undetectable4p65B-5yjhA:undetectable4p65F-5yjhA:undetectable4p65H-5yjhA:undetectable | 4p65A-5yjhA:undetectable4p65B-5yjhA:undetectable4p65F-5yjhA:undetectable4p65H-5yjhA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5zvt | C-TERMINUS OF OUTERCAPSID PROTEIN VP5 (Aquareovirus C) |
no annotation | 5 | LEU B 280ALA B 276HIS B 513LEU B 514LEU B 273 | None | 1.24A | 4p65A-5zvtB:undetectable4p65B-5zvtB:undetectable4p65F-5zvtB:undetectable4p65H-5zvtB:undetectable | 4p65A-5zvtB:undetectable4p65B-5zvtB:undetectable4p65F-5zvtB:undetectable4p65H-5zvtB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6c9k | DARP14 - SUBUNIT AWITH DARPIN (syntheticconstruct) |
no annotation | 5 | LEU A 37LEU A 146ALA A 122LEU A 87LEU A 153 | None | 1.26A | 4p65A-6c9kA:undetectable4p65B-6c9kA:undetectable4p65F-6c9kA:undetectable4p65H-6c9kA:undetectable | 4p65A-6c9kA:undetectable4p65B-6c9kA:undetectable4p65F-6c9kA:undetectable4p65H-6c9kA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6d6y | APRAMETHYLTRANSFERASE 2 (Mooreabouillonii) |
no annotation | 5 | LEU A 555HIS A 546ALA A 558LEU A 539LEU A 576 | None | 1.22A | 4p65A-6d6yA:undetectable4p65B-6d6yA:undetectable4p65F-6d6yA:undetectable4p65H-6d6yA:undetectable | 4p65A-6d6yA:undetectable4p65B-6d6yA:undetectable4p65F-6d6yA:undetectable4p65H-6d6yA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6frl | TRYPTOPHANHALOGENASESUPERFAMILY (Brevundimonassp. BAL3) |
no annotation | 5 | CYH A 335LEU A 233ALA A 232LEU A 205LEU A 195 | None | 1.20A | 4p65A-6frlA:undetectable4p65B-6frlA:undetectable4p65F-6frlA:undetectable4p65H-6frlA:undetectable | 4p65A-6frlA:undetectable4p65B-6frlA:undetectable4p65F-6frlA:undetectable4p65H-6frlA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6frl | TRYPTOPHANHALOGENASESUPERFAMILY (Brevundimonassp. BAL3) |
no annotation | 5 | CYH A 335LEU A 233ALA A 232LEU A 205LEU A 195 | None | 1.27A | 4p65A-6frlA:undetectable4p65B-6frlA:undetectable4p65F-6frlA:undetectable4p65H-6frlA:undetectable | 4p65A-6frlA:undetectable4p65B-6frlA:undetectable4p65F-6frlA:undetectable4p65H-6frlA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fx0 | RETINOIC ACIDRECEPTOR GAMMA (Homo sapiens) |
no annotation | 5 | LEU A 357HIS A 197LEU A 330ALA A 333LEU A 248 | None | 1.26A | 4p65A-6fx0A:undetectable4p65B-6fx0A:undetectable4p65F-6fx0A:undetectable4p65H-6fx0A:undetectable | 4p65A-6fx0A:undetectable4p65B-6fx0A:undetectable4p65F-6fx0A:undetectable4p65H-6fx0A:undetectable |